These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25360888)

  • 1. Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1.
    Würtz M; Nissen PH; Grove EL; Kristensen SD; Hvas AM
    PLoS One; 2014; 9(10):e111816. PubMed ID: 25360888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
    Xu K; Ye S; Zhang S; Yang M; Zhu T; Kong D; Chen J; Xu L; Li J; Zhu H; Wang F; Yang L; Zhang J; Fan Y; Ying L; Hu X; Zhang X; Chan NC; Li C
    Circ Cardiovasc Interv; 2019 May; 12(5):e007019. PubMed ID: 31018667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.
    Lewis JP; Ryan K; O'Connell JR; Horenstein RB; Damcott CM; Gibson Q; Pollin TI; Mitchell BD; Beitelshees AL; Pakzy R; Tanner K; Parsa A; Tantry US; Bliden KP; Post WS; Faraday N; Herzog W; Gong Y; Pepine CJ; Johnson JA; Gurbel PA; Shuldiner AR
    Circ Cardiovasc Genet; 2013 Apr; 6(2):184-92. PubMed ID: 23392654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability.
    Herrera-Galeano JE; Becker DM; Wilson AF; Yanek LR; Bray P; Vaidya D; Faraday N; Becker LC
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1484-90. PubMed ID: 18511696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Evaluation of Genetic Variation in Platelet Endothelial Aggregation Receptor 1 Reveals Aspirin-Dependent Effects on Platelet Aggregation Pathways.
    Backman JD; Yerges-Armstrong LM; Horenstein RB; Newcomer S; Shaub S; Morrisey M; Donnelly P; Drolet M; Tanner K; Pavlovich MA; O'Connell JR; Mitchell BD; Lewis JP
    Clin Transl Sci; 2017 Mar; 10(2):102-109. PubMed ID: 28075528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
    PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
    Lepäntalo A; Mikkelsson J; Reséndiz JC; Viiri L; Backman JT; Kankuri E; Karhunen PJ; Lassila R
    Thromb Haemost; 2006 Feb; 95(2):253-9. PubMed ID: 16493486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
    Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C
    Thromb Res; 2011 Jul; 128(1):47-53. PubMed ID: 21429568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.
    Bierend A; Rau T; Maas R; Schwedhelm E; Böger RH
    Br J Clin Pharmacol; 2008 Apr; 65(4):540-7. PubMed ID: 17995973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.
    Peng LL; Zhao YQ; Zhou ZY; Jin J; Zhao M; Chen XM; Chen LY; Cai YF; Li JL; Huang M
    Acta Pharmacol Sin; 2016 Nov; 37(11):1442-1448. PubMed ID: 27641736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    PLoS One; 2015; 10(5):e0126767. PubMed ID: 25993271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ABO locus is associated with increased platelet aggregation in patients with stable coronary artery disease.
    Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Würtz M; Grove EL; Hvas AM; Jensen HK; Kristensen SD
    Int J Cardiol; 2019 Jul; 286():152-158. PubMed ID: 30837090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression.
    Faraday N; Yanek LR; Yang XP; Mathias R; Herrera-Galeano JE; Suktitipat B; Qayyum R; Johnson AD; Chen MH; Tofler GH; Ruczinski I; Friedman AD; Gylfason A; Thorsteinsdottir U; Bray PF; O'Donnell CJ; Becker DM; Becker LC
    Blood; 2011 Sep; 118(12):3367-75. PubMed ID: 21791418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin in coronary artery disease: an appraisal of functions and limitations.
    Würtz M
    Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the Association of PEAR1, P2Y12, and UGT2A1 Polymorphisms with Platelet Reactivity in Response to Dual Antiplatelet Therapy in Chinese Patients.
    Zhang S; Zhu J; Li H; Wang L; Niu J; Zhu B; He L; Shen L; Qin S; Fang S
    Cardiology; 2018; 140(1):21-29. PubMed ID: 29635252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction.
    Larsen SB; Neergaard-Petersen S; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2012 Jul; 108(1):140-7. PubMed ID: 22534977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplate
    Roullet S; Labrouche S; Carrie C; Auque H; Berard X; Freyburger G
    J Thromb Haemost; 2018 Mar; 16(3):583-591. PubMed ID: 29314596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of PEAR1, PTGS1 gene polymorphisms on the recurrence of aspirin-treated patients with ischemic stroke in the Han population of China: A 4-year follow-up study.
    Zhang L; Meng Z; Wang H; Miao Y
    Medicine (Baltimore); 2024 May; 103(19):e38031. PubMed ID: 38728491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
    Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.